1st Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety, prescription drug abuse, value of prescription drugs; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4366 (118th), H.R. 2882 (118th)

Medicare/Medicaid MMM

Issues related to implementation of Inflation Reduction Act of 2022 (PL 117-169)

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Issues related to biosecurity

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.